Carcinogenesis

You have full text access to this OnlineOpen article

Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein

  1. Tobias Bäuerle1,
  2. Hassan Adwan1,
  3. Fabian Kiessling2,
  4. Heidegard Hilbig3,
  5. Franz P. Armbruster4,
  6. Martin R. Berger1,†,*

Article first published online: 1 FEB 2005

DOI: 10.1002/ijc.20840

Issue

International Journal of Cancer

International Journal of Cancer

Volume 115, Issue 2, pages 177–186, 1 June 2005

Additional Information

How to Cite

Bäuerle, T., Adwan, H., Kiessling, F., Hilbig, H., Armbruster, F. P. and Berger, M. R. (2005), Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein. Int. J. Cancer, 115: 177–186. doi: 10.1002/ijc.20840

Author Information

  1. 1

    Unit of Toxicology and Chemotherapy, Deutsches Krebsforschungszentrum Heidelberg, Heidelberg, Germany

  2. 2

    Department of Medical Physics in Radiology, Deutsches Krebsforschungszentrum Heidelberg, Heidelberg, Germany

  3. 3

    Institute of Anatomy, University of Leipzig, Leipzig, Germany

  4. 4

    Immundiagnostik AG, Bensheim, Germany

  1. †

    Fax: +49-6221-423313.

*Unit of Toxicology and Chemotherapy, Deutsches Krebsforschungszentrum Heidelberg, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany

Publication History

  1. Issue published online: 21 MAR 2005
  2. Article first published online: 1 FEB 2005
  3. Manuscript Accepted: 19 OCT 2004
  4. Manuscript Received: 26 APR 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (568K)

References

  • 1
    Coleman RE. Skeletal complications of malignancy. Cancer 1997; 80: 1588–94.
    Direct Link:
  • 2
    Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer 1987; 55: 61–6.
  • 3
    Diel IJ, Solomayer EF, Seibel MJ, Pfeilschifter J, Maisenbacher H, Gollan C, Pecherstorfer M, Conradi R, Kehr G, Boehm E, Armbruster FP, Bastert G. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin Cancer Res 1999; 5: 3914–9.
  • 4
    Bellahcène A, Menard S, Bufalino R, Moreau L, Castronovo V. Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. Int J Cancer 1996; 69: 350–3.
    Direct Link:
  • 5
    Fisher LW, Torchia DA, Fohr B, Young MF, Fedarko NS. Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 2001; 280: 460–5.
  • 6
    Ganss B, Kim RH, Sodek J. Bone sialoprotein. Crit Rev Oral Biol Med 1999; 10: 79–98.
  • 7
    Rosol TJ, Tannehill-Gregg SH, LeRoy BE, Mandl S, Contag CH. Animal models of bone metastasis. Cancer 2003; 97: 748–57.
    Direct Link:
  • 8
    Hebel R, Stromberg MW. Anatomy and embryology of the laboratory rat, 2nd ed. Wörthersee: BioMed Verlag, 1986.
  • 9
    Price JE. Metastasis from human breast cancer cell lines. Br Cancer Res Treat 1996; 39: 93–102.
  • 10
    Lelekakis M, Moseley JM, Martin TJ, Hards D, Williams E, Ho P, Lowen D, Javni J, Miller FR, Slavin J, Anderson RL. A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis 1999; 17: 163–7.
  • 11
    Peyruchaud O, Winding B, Pécheur I, Serre CM, Delmas P, Clézardin P. Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions. J Bone Miner Res 2001; 16: 2027–34.
    Direct Link:
  • 12
    Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 2001; 16: 1486–95.
    Direct Link:
  • 13
    Kjønniksen I, Winderen M, Bruland Ø, Fodstat Ø. Validity and usefulness of human tumor models established by intratibial cell inoculation in nude rats. Cancer Res 1994; 54: 1715–9.
  • 14
    Neudert M, Fischer C, Krempien B, Bauss F, Seibel MJ. Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumor growth. Int J Cancer 2003; 107: 468–77.
    Direct Link:
  • 15
    Paulus MJ, Gleason SS, Kennel SJ, Hunsicker PR, Johnson DK. High resolution X-ray computed tomography: an emerging tool for small animal cancer research. Neoplasia 2000; 2: 62–70.
  • 16
    Mastro AM, Gay CV, Welch DR. The skeleton as a unique environment for breast cancer cells. Clin Exp Metastasis 2003; 20: 275–84.
  • 17
    Bellahcène A, Antoine N, Clausse N, Tagliabue E, Fisher LW, Kerr JM, Jarès P, Castronovo V. Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribounucleic acid levels. Lab Invest 1996; 75: 203–10.
  • 18
    Bellahcène A, Castronovo V. Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases. Bull Cancer 1997; 84: 17–24.
  • 19
    Ibrahim T, Leong I, Sanchez-Sweatman O, Khokha R, Sodek J, Tenenbaum HC, Ganss B, Cheifetz S. Expression of bone sialoprotein and osteopontin in breast cancer bone metastases. Clin Exp Metastasis 2000; 18: 253–60.
  • 20
    Carlinfante G, Vassiliou D, Svensson O, Wendel M, Heinegård D, Andersson G. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma. Clin Exp Metastasis 2003; 20: 437–44.
  • 21
    Waltregny D, Bellahcène A, De Leval X, Florkin B, Weidle U, Castronovo V. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers. J Bone Miner Res 2000; 15: 834–43.
    Direct Link:
  • 22
    Zhang JH, Tang J, Wang J, Ma W, Zheng W, Yoneda T, Chen J. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model. Int J Oncol 2003; 23: 1043–8.
  • 23
    Chen J, Rodriguez JA, Barnett B, Hashimoto N, Tang J, Yoneda T. Bone sialoprotein promotes tumor cell migration in both in vitro and in vivo models. Connect Tissue Res 2003; 44: 279–84.
  • 24
    Adwan H, Bäuerle TJ, Berger MR. Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells. Cancer Gene Ther 2004; 11: 109–20.
  • 25
    Sung V, Stubbs JT3rd, Fisher L, Aaron AD, Thompson EW. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins. J Cell Physiol 1998; 176: 482–94.
    Direct Link:
  • 26
    Pecheur I, Peyruchaud O, Serre CM, Guglielmi J, Voland C, Bourre F, Margue C, Cohen-Solal M, Buffet A, Kieffer N, Clézardin P. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J 2002; 16: 1266–8.
  • 27
    Pilch J, Habermann R, Felding-Habermann B. Unique ability of integrin alpha(v)beta3 to support tumor cell arrest under dynamic flow conditions. J Biol Chem 2002; 277: 21930–8.
  • 28
    Felding-Habermann B. Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 2003; 20: 203–13.
  • 29
    Fedarko NS, Jain A, Karadag A, Fisher LW. Three small integrin-binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J 2004; 18: 734–6.
  • 30
    Freije JM, Balbin M, Pendas AM, Sanchez LM, Puente XS, Lopez-Otin C. Matrix metalloproteinases and tumor progression. Adv Exp Med Biol 2003; 532: 91–107.
  • 31
    Adwan H, Bäuerle T, Najajreh Y, Elazer V, Golomb G, Berger MR. Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells. Int J Oncol 2004; 24: 1235–44.
View Full Article (HTML) Get PDF (568K)